CRP and depressive symptom measurement: Conversely, persons with low CRP (<5 mg/L) levels who were administered placebo experienced a greater reduction in depressive symptoms in comparison to those administered infliximab, a finding that argues against administration of anti-inflammatory agents in cases of depression without apparent inflammation (Raison et al., 2013).